16 January 2018
The group Evultis SA – Friulchem S.p.A. started a new collaboration in China that allows it to be up to date on the market situation and to be able to satisfy customers requests promptly.
This way the group will be faster in providing the information to the partners.
11 January 2018
DCAT Value Chain Insights published a new article on Patent Ruling for Rifaximin.
Mexican Institute of Industrial Property (IMPI), the patent and trademark administration body of Mexico, recently dismissed a patent-infringement and unfair competition case filed against Interquim, S.A. de C.V.
23 November 2017
Friulchem S.p.A. has filed FC-Cubes patents in EU, US, BRASIL, AUSTRALIA, and MX. The idea started from it is not easy to administer oral medicines to pets. Many owners try to hide tablets in a piece of meat or cheese to give it to their cat or dog. While for the horses they have to deal mainly with products in powder or paste forms. It rarely works: the animal eats the treat and neglects the tablet. Tablets usually produced by extrusion.
Friulchem identified a different manufacturing method, which allows reaching a chewable matrix with all the benefits presented for the drugs already on the market, but without the limits connected to production by extrusion.
Friulchem technology is based on a compression stage, which shows different advantages compared to extrusion:
- Compression provides full control over the weight of the chewable cube and hence over the quantity of API contained in each unit of the finished product, thereby guaranteeing compliance with treatment;
- By compression the outcome could be obtained in different shapes, from the typical square to new “suggestions” heart, bones, fish-shape).
Additionally, FC-Cubes could be manufactured with higher fat and palatable material content, which leads to perfect appetency (total ingestion by animals even on a repeat basis). The compositions of the matrix developed in Friulchem is high palatable and able to mask also active components which are particularly disliked by the animals.
6 November 2017
Friulchem S.p.A. is the beneficiary of contribution from Tender POR FESR 2014-2020. Activity 2.3.a.1 “Assistance in support of technological investments of small and medium-size enterprises (SMI)” – Tender DGR 1898 of 07/10/2016 for project titled TECHNOLOGICAL INNOVATION FOR THE ANALYSIS LABORATORY, financially supported by the European Union, the Republic of Italy and the Autonomous Region of Friuli Venezia Giulia.
The project entails the purchase of two pieces of equipment to be installed in the analysis laboratory. Such devices are needed to carry out analyses on substances or substance compounds. The investment also concerns the purchase of two PCs each to be connected to each device.
Project’s main objectives:
- 10% increase in the laboratory’s production capacity (increase of number of samples to be analyzed within a certain amount of time);
- Increase of the analysis laboratory’s competitiveness, thanks to the availability of a faster and more advanced service;
- Increase of the overall competitiveness of the company within the market.
The project was approved with an admissible cost of € 108,189.60 and we were awarded a financial contribution of € 41,562.28.
Friulchem S.p.A. è beneficiaria di un contributo a valere sul Bando POR FESR 2014-2020. Attività 2.3.a.1 “Aiuti agli investimenti tecnologici delle PMI” – Bando DGR 1898 del 07/10/2016 con un progetto dal titolo INNOVAZIONE TECNOLOGICA PER IL LABORATORIO DI ANALISI, con il supporto finanziario da parte dell’Unione Europea, dalla Repubblica Italiana e dalla Regione Autonoma Friuli Venezia Giulia.
Il progetto prevede l’acquisto di due apparecchiature specifiche da inserire nel laboratorio di analisi. Tali apparecchiature sono necessarie per la realizzazione di analisi sulle sostanze o su miscele di sostanze. L’investimento riguarda anche l’acquisto di due PC da collegare a ciascuna apparecchiatura.
Obiettivi principali del progetto:
- Incremento della capacità produttiva del laboratorio (incremento del numero di campioni analizzabili per unità di tempo) del 10%;
- Incremento della competitività del laboratorio di analisi offrendo un servizio più avanzato e veloce;
- Incremento della competitività complessiva dell’impresa all’interno del mercato.
Il progetto è stato approvato con una spesa ammessa di € 108.189,60 e ci è stato concesso un contributo di € 41.562,28.
20 October 2017
Friulchem S.p.A is installing a new micronization unit at its facility in Vivaro, Italy.
This new installation in the Vivaro plant will allow Friulchem to increase its micronization capacity by 1.8 times current capacity (from 250 kg/day up to 700 kg/day), and it will be operational this autumn.
FC Micronization Technology ensures the products’ particle size homogeneity and stability because it works under highly pure nitrogen flow, thus safeguarding products during the micronization process.
Contact firstname.lastname@example.org for more information.
14 September 2017
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt.
Contact email@example.com and meet our team at CPhI Worldwide 2017 to discover our news on human, cosmetic & veterinary divisions.
5 August 2017
DCAT Week 2018 is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT) to assist its member companies with their business development objectives.
23 March 2017
The pet industry in the US and many other countries is booming.
According to the American Pet Product Association (APPA), Americans spent approximately $58 billion on pet products and services in 2014.